Cargando…

Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection

Treatment of chronic hepatitis C virus (HCV) infection with direct‐acting antivirals results in a rapid decline in viral load and markers of hepatic inflammation, including serum chemokine (C‐X‐C motif) ligand 10 (CXCL10) concentration, which is followed in most cases by a sustained virologic respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meissner, Eric G., Kohli, Anita, Higgins, Jeanette, Lee, Yu‐Jin, Prokunina, Olga, Wu, David, Orr, Cody, Masur, Henry, Kottilil, Shyam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703427/ https://www.ncbi.nlm.nih.gov/pubmed/29202115 http://dx.doi.org/10.1002/hep4.1074

Ejemplares similares

Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8(+) T-Cell Function
por: Orr, Cody, et al.
Publicado: (2021)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020)

Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014)

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy
por: Meissner, Eric G., et al.
Publicado: (2015)

Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
por: Meissner, E. G., et al.
Publicado: (2016)

HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
por: Poonia, Bhawna, et al.
Publicado: (2018)

Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
por: Shrivastava, Shikha, et al.
Publicado: (2018)

CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients
por: Shrivastava, Shikha, et al.
Publicado: (2021)

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
por: Tang, Lydia Shuk Yee, et al.
Publicado: (2016)

1067. Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
por: Mathur, Poonam, et al.
Publicado: (2020)

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study
por: Petersen, Tess, et al.
Publicado: (2015)

Genetics of the Human Interferon Lambda Region
por: Prokunina-Olsson, Ludmila
Publicado: (2019)

Interferon γ Is Required for Activation-induced Death of T Lymphocytes
por: Refaeli, Yosef, et al.
Publicado: (2002)

Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection
por: Chaudhury, Chloe, et al.
Publicado: (2017)

Induction of γ‐Interferon by Avarol in Human Peripheral Blood Lymphocytes
por: Voth, Rita, et al.
Publicado: (1988)

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
por: Ghosh, Alip, et al.
Publicado: (2020)

Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection
por: Carrero, Javier A., et al.
Publicado: (2004)

Modulation of immune checkpoint regulators in interferon γ induced urothelial carcinoma and activated T-lymphocyte cells by cytostatics
por: Hänze, Jörg, et al.
Publicado: (2023)

Moderate Exercise Enhances the Production of Interferon-γ and Interleukin-12 in Peripheral Blood Mononuclear Cells
por: Zamani, Alireza, et al.
Publicado: (2017)

Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of Individuals With Fibromyalgia
por: Fineschi, Serena, et al.
Publicado: (2022)

The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?
por: Nguyen, Thi Huyen Tram, et al.
Publicado: (2017)

MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-α
por: Zhang, Xiaozhen, et al.
Publicado: (2013)

Transcriptional Regulation of Latent Feline Immunodeficiency Virus in Peripheral CD4+ T-lymphocytes
por: McDonnel, Samantha J., et al.
Publicado: (2012)

ACE2 is not induced by interferon
por: Saffern, Miriam
Publicado: (2020)

A detailed characterization of peripheral blood lymphocytes in patients with myeloproliferative disease treated with pegylated-interferon alpha
por: Kovacsovics-Bankowski, Magdalena, et al.
Publicado: (2015)

A NEW SURFACE MARKER ON T LYMPHOCYTES OF HUMAN PERIPHERAL BLOOD
por: Hammarström, Sten, et al.
Publicado: (1973)

Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
por: Cheknev, S. B., et al.
Publicado: (1994)

HORMONE-STIMULATED EXOCYTOSIS IN THE TOAD URINARY BLADDER : Some Possible Implications for Turnover of Surface Membranes
por: Masur, Sandra K., et al.
Publicado: (1972)

Type I and type III interferon in opposition?
por: Park, Matthew D.
Publicado: (2020)

Impaired interferon signature in severe COVID-19
por: Gruber, Conor
Publicado: (2020)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

2072. Of Mice and Men: HIV-induced CD38 expression on CD8+ T lymphocytes contributes to mitochondrial dysfunction and chronic inflammation despite antiretroviral therapy
por: Mathur, Poonam, et al.
Publicado: (2022)

On-Treatment Elevation in Hepatic Transaminases during HCV Treatment with Ombitasvir, Paritaprevir, Dasabuvir, Ritonavir, and Ribavirin: A Case Series
por: Bean, Madelyne, et al.
Publicado: (2016)

1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study
por: Mathur, Poonam, et al.
Publicado: (2018)

49483 Evaluating the Role of IFNLR1 Receptor Dynamics and Plasticity in Regulating Cellular Response to Interferons
por: Evans, Gray, et al.
Publicado: (2021)

158 Hepatitis C Treatment Update: Current Status and Future Direcctions
por: Kottilil, Shyam
Publicado: (2014)

Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment
por: Hashimoto, Satoru, et al.
Publicado: (2016)

Human gamma interferon strongly upregulates its own gene expression in peripheral blood lymphocytes
Publicado: (1989)

Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes
por: O'Bryan, Joel M., et al.
Publicado: (2011)

In Vitro Release of Interferon-Gamma from Peripheral Blood Lymphocytes in Cutaneous Adverse Drug Reactions
por: Goldberg, Ilan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5k0nh5vtgncsorbmr2kqtp5kj7